Trial of MR-guided Focused Ultrasound for Treatment of Refractory Major Depression

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 19, 2018

Primary Completion Date

July 28, 2021

Study Completion Date

July 28, 2021

Conditions
Major Depressive Disorder
Interventions
DEVICE

MR-guided Focused Ultrasound

Focused Ultrasound allows for non-invasive thermal ablation of soft tissue virtually anywhere in the body. Treatment begins by acquiring a series of magnetic resonance (MR) images of the target tissue. The physician then reviews the images on the system workstation, identifies the target, delineates treatment contours, and reviews the treatment plan. Therapy planning software calculates the parameters required to effectively treat (e.g. ablate) the defined region. During treatment, the patient wears a helmet equipped with multiple sources of ultrasound which generate a point of focused energy, called a sonication. The sonication raises the tissue temperature within a well-defined region, causing a thermal coagulation effect.

Trial Locations (1)

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
lead

Sunnybrook Health Sciences Centre

OTHER

NCT03421574 - Trial of MR-guided Focused Ultrasound for Treatment of Refractory Major Depression | Biotech Hunter | Biotech Hunter